Yoshihiko Kotake

USPTO Granted Patents = 26 (Patent Applications = 3)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 8 (Patent Applications = 7)

Average Co-Inventor Count = 10.2

ph-index = 7

Forward Citations = 229(Granted Patents)

Location History:

Tsuchiura, JP (2007)
Tsuchirua, JP (2016)
Tsukuba, JP (2010 - 2020)
Ibaraki, JP (1993 - 2024)

Company Filing History:

16 out of 677

Eisai Company, Limited

patents

10 out of 527

Eisai R&d Management Co., Ltd.

where one patent can have more than one assignee

Years Active: 1993-2024

Loading Chart...

26 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11926619 - Certain pladienolide compounds and methods of use (2024-03-12),

2. 10745387 - Crystalline form of (2S,3S,6S,7R,10R,E)-7,10-dihydroxy-3,7-dimethyl-12-oxo-2-((R,2E,4E)-6-(piridin-2-yl)hepta-2,4-dien-2-yl)oxacyclododec-4-en-6-yl-4-methylpiperazine-1-carboxylate and methods of use thereof (2020-08-18),

3. 9481669 - Pladienolide pyridine compounds and methods of use (2016-11-01),

4. 7893068 - Physiologically active substances (2011-02-22),

5. 7884128 - Process for total synthesis of pladienolide B and pladienolide D (2011-02-08),

6. 7816401 - Process for total synthesis of pladienolide B and pladienolide D (2010-10-19),

7. 7667052 - Bioactive substance (2010-02-23),

8. 7619100 - Physiologically active substances (2009-11-17),

9. 7550503 - Physiologically active substances (2009-06-23),

10. 7396836 - Pyrimidine compound and medicinal composition thereof (2008-07-08),

11. 7256178 - Physiologically active substances (2007-08-14),

12. 7189717 - Medicinal compositions promoting bowel movement (2007-03-13),

13. 7160892 - Pyrimidone compounds and pharmaceutical compositions containing the same (2007-01-09),

14. 7026352 - Physiologically active substances (2006-04-11),

15. 5952335 - Fused polycyclic heterocycle derivatives (1999-09-14),

Certainly! Here's the article about inventor Yoshihiko Kotake:

Title: Yoshihiko Kotake: Pioneering Innovations in Cancer Treatment

Introduction:

Yoshihiko Kotake, a visionary inventor hailing from Ibaraki, Japan, has made significant contributions to the field of pharmaceuticals through his relentless pursuit of innovation and his passion for tackling complex challenges.

Latest Patents:

Among his impressive portfolio of 26 patents, Yoshihiko Kotake's latest inventions have been groundbreaking. One of his recent patents involves certain pladienolide compounds and methods of their use in treating various types of cancers by targeting the spliceosome and mutations therein. Another notable patent is for the crystalline form of a specific compound that shows promise in cancer treatment.

Career Highlights:

Having worked with esteemed companies such as Eisai Company, Limited and Eisai R&D Management Co., Ltd., Yoshihiko Kotake has been at the forefront of developing cutting-edge pharmaceutical solutions aimed at improving the lives of patients battling cancer. His innovative approach and dedication to research have set him apart as a trailblazer in the global tech community.

Collaborations:

Throughout his career, Yoshihiko Kotake has collaborated with top professionals in the industry, including Jun Niijima and Norihiro Ueda. Together, they have combined their expertise to push the boundaries of pharmaceutical innovation and bring forth novel therapies for cancer patients.

Conclusion:

Yoshihiko Kotake's unwavering commitment to innovation and his remarkable contributions to the field of pharmaceuticals highlight his status as a visionary inventor. His groundbreaking patents and successful collaborations underscore his dedication to creating impactful solutions to the most challenging healthcare problems.

This text is generated by artificial intelligence and may not be accurate.